Muntasir Abo Al Hayja

Muntasir Abo Al Hayja

Auto-generated profile, based on publicly available information

Muntasir Abo Al Hayja

Cardiology Department, Royal Liverpool University Hospital, L7 8YE Liverpool, UK

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2025 in European Cardiology Review
Verified
Journal Article
Open access
PDF file
AEAhmed Elamin
Ahmed Elamin
MAMustafa Abdimalik
Mustafa Abdimalik
MAMohanad Abdelrahim
Mohanad Abdelrahim
MHMuntasir Abo Al Hayja
Muntasir Abo Al Hayja
TFTim Fairbairn
Tim Fairbairn
MFMichael Fisher
Michael Fisher
Coronary microvascular dysfunction (CMD) is being increasingly recognised as a significant contributor to myocardial ischaemia, particularly in patients without obstructive coronary artery disease. This review explores the anatomy and physiology of the coronary microcirculation, emphasising the role of endothelial dysfunction and endothelin-1 in CMD pathogenesis. We discuss diagnostic approaches, including invasive and non-invasive techniques, such as PET, cardiac MRI and intracoronary physiological testing. Current management strategies focus on risk factor modification and tailored pharmacotherapy, with emerging therapies targeting endothelin pathways. A comprehensive understanding of CMD is essential for improving diagnostic accuracy and developing effective treatments for patients presenting with ischaemic symptoms absent of angiographic evidence of coronary obstruction.

22 July 2026 in Reviews in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
AHAllam Harfoush
Allam Harfoush
THTammam Harfouch
Tammam Harfouch
MAMuntasir Abo-Al-Hayja
Muntasir Abo-Al-Hayja
KAKhaled Albouaini
Khaled Albouaini
AEAmmar Ezeldin
Ammar Ezeldin
AIAbdalazeem Ibrahem
Abdalazeem Ibrahem
Background:Undeflatable coronary balloons during percutaneous coronary intervention (PCI) are rare but particularly hazardous because persistent intracoronary inflation can cause abrupt coronary occlusion, ischaemia, and haemodynamic collapse. We aimed to synthesise the published experience to define mechanistic patterns, identify recurring predisposing factors, and propose a practical bailout algorithm.Methods and Results:We performed a case-based review of PubMed, the Cochrane Library, and EBSCO from inception to February 2026. Eligible reports described balloons that could not be deflated while positioned in a coronary artery. A total of 15 coronary cases (2011–2025) met the inclusion criteria. Events occurred most often during post-dilatation or after stent deployment in complex anatomy, frequently involving severe calcification, aorto-ostial segments, chronic total occlusion-like lesions, and settings with limited guide engagement. Mechanistic patterns clustered into (i) intact-system non-deflation, where restoration of an exit pathway (system checks, sustained negative suction, and contrast dilution), followed by controlled decompression (wire puncture or mechanical- or energy-assisted disruption), was feasible; (ii) shaft-compromised events (fracture or detachment), where management shifted from decompression to mechanical retrieval, with surgery reserved for percutaneous failure.Conclusion:Undeflatable coronary balloons represent distinct failure modes with different viable rescue options. Outcomes appear to be driven by rapid restoration of perfusion and early recognition of shaft integrity. A structured escalation approach prioritising stabilisation, low-risk troubleshooting, controlled decompression, and decisive transition to retrieval, exclusion, or surgery when decompression is impossible could reduce secondary iatrogenic harm.